Search for: "Purdue Pharma Inc." Results 81 - 100 of 152
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Nov 2017, 8:59 pm by Brenda Fulmer
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
4 May 2011, 7:52 am by Tron Emptage
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma   Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms   Morphine Kadian® Extended Release Capsules Actavis   Morphine MS Contin Extended Release Tablets … [read post]
12 Jul 2022, 9:38 am by Kelly Shivery
  We suspect the Purdue Pharma opioid settlement skewed the 2021 statistics. [read post]
12 Jul 2022, 9:38 am by Kelly Shivery
  We suspect the Purdue Pharma opioid settlement skewed the 2021 statistics. [read post]
8 Feb 2017, 3:09 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
24 Apr 2014, 7:39 am by Alexander Barthet
Thamarr Griffith is founder of GrifCo Inc., who has developed and serviced multimillion dollar accounts for Fortune 500 companies including Johnson & Johnson, ZOLL Medical, Purdue Pharma and Black & Decker’s DeWalt Industrial Power Tools division. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
13 Oct 2016, 6:50 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]